NetScientific PLC Confirmed Start Date for Ian Postlethwaite as CFO (8030A)
10 Junho 2016 - 3:30AM
UK Regulatory
TIDMNSCI
RNS Number : 8030A
NetScientific PLC
10 June 2016
("NetScientific" or the "Company" or the "Group")
Netscientific Confirms Start Date for Ian Postlethwaite as
CFO
London, UK - 10 June 2016 - NetScientific plc ("NetScientific",
AIM:NSCI), the transatlantic biomedical and healthcare technology
group, is pleased to confirm that further to the Company's
announcement of his appointment on 5th April 2016, new Chief
Financial Officer Ian Postlethwaite will join the Company on the
13th June 2016 and will join the Board immediately following the
Company's Annual General Meeting on 15th June 2016.
Commenting on the appointment, Sir Richard Sykes, Chairman of
NetScientific, said: "We are pleased to welcome Ian as our new
Chief Financial Officer. This is an important period for
NetScientific as we move forward with a renewed focus on digital
health, diagnostics and therapeutics. Ian's extensive experience in
the healthcare sector and the capital markets will prove invaluable
as the Company continues to progress.
"I would like to take this opportunity to thank Mark Nanovich
for his excellent contribution as Interim CFO during this
period."
Ian Postlethwaite commented: "This is an exciting time to be
joining NetScientific and I look forward to working with CEO,
Francois Martelet and the management team to deliver value across
our portfolio of high-quality assets focused on dynamic new areas
in healthcare."
- Ends -
For more information, please contact:
NetScientific Tel: +44 (0)20 3514 1800
François R. Martelet,
M.D., CEO
Mark Nanovich, Interim
CFO
Investec (NOMAD and Tel: +44 (0)20 7597 4000
broker)
Gary Clarence / Daniel
Adams
Consilium Strategic Tel: +44 (0)20 3709 5700
Communications netscientific@consilium-comms.com
Mary-Jane Elliott /
Chris Gardner / Jessica
Hodgson / Chris Welsh
/ Laura Thornton
About NetScientific Plc
NetScientific is a biomedical and healthcare technology group
that funds and develops technologies that offer transformative
benefits to people's lives and society through improved diagnosis,
prognosis and treatment. For more information, please visit the
website at www.netscientific.net.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCDDGDLBSGBGLC
(END) Dow Jones Newswires
June 10, 2016 02:30 ET (06:30 GMT)
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024